Regulatory News
Wednesday, August 31, 2016
BRIEF-Allergan and Adamas enter settlement with Amneal Pharmaceuticals
* Allergan and Adamas announce settlement with Amneal
related to namzaric patent litigation
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment